The share price is near the lows of the year, and investors want to know the cause.
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFA04 Sept 2025, 19:45 UTC
AI-generated source summary
The analysis focuses on Atlassian's (TEAM) stock. The analyst discusses the company's fiscal year 2025, highlighting revenue of $5.2 billion and free cash flow of $1.4 billion and management's confidence to produce 20% revenue growth for fiscal years between now and 2027. The company's 4th quarter was emphasized for signing a record number of deals greater than $1 million in ACV, up over 2x year-over-year. Cloud net revenue retention rate of 120%. The analyst reports that their intrinsic value per share calculation has them valuing the company at $343.77. At a current market price of $172.55, the analyst has a buy rating on Atlassian stock.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from Parkev Tatevosian, CFA
Coca-Cola Stock: Buy, Hold, or Sell? | KO Stock Analysis
SoFi Stock Analysis: Buy the Dip?
Should You Buy Micron Stock Instead of Nvidia Stock? | MU Stock vs. NVDA Stock
Should You Buy the Dip in Meta Stock? | META Stock Analysis and Live Earnings Review
Should Passive Income Investors Buy Colgate Palmolive Stock?
Procter & Gamble Stock: Buy, Hold, or Sell? | PG Stock Analysis
Parkev Tatevosian, CFA
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.